Belépés

NCT07868081Toborzás még nem indult

A Study to Better Understand the Diagnosis and Treatment of Polycythaemia Vera

Knowledge, Attitudes and Practices Through Unified Real-world Experimental Vignettes in Polycythemia Vera (PV): KAPTURE-PV, a Multi-Country Vignette-Based Observational Study

Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. okt. 9.

Rövid összefoglaló (regiszter, angolul)

PV is a rare, long-term blood cancer that causes the body to make too many blood cells. This can make the blood thicker than normal and the risk of blood clots higher. People with PV often experience symptoms that can affect their daily lives. Understanding how doctors diagnose and treat PV in everyday medical practice in a certain country can help find the differences in knowledge, diagnosis, and treatment of PV across countries. This study will not review or collect data from actual people with PV. It will collect information on the diagnosis and treatment of PV using a standard set of questions on and examples of fictional (unreal) people with PV. This is called clinical vignette. The study will ask doctors from several countries to complete this survey. The main aim of this study is to better understand how well doctors know about and diagnose PV and how they treat PV in certain countries. Other aims are to better understand how PV is managed and treated in everyday medical practice across countries. This includes which treatment people with PV receive once they are diagnosed and how access to medicines and healthcare services and other factors affects a doctor's treatment decisions for PV.

Állapot (regiszter)
Toborzás még nem indult
Vizsgálattípus
Megfigyeléses
Résztvevők száma
90 (tervezett)
Első benyújtás
2026. okt. 5.
Kezdés
2026. dec. 1.
Elsődleges befejezés
2027. márc. 1.
Fő szponzor
Takeda
NCT-szám
NCT07868081

Mit vállalsz

  • Vizsgálat típusa: Megfigyeléses
  • Tervezett résztvevők: 90
  • 2026. dec. 1. és az elsődleges befejezés (2027. márc. 1.) között
  • Nincs megadott helyszín, ország nélkül
  • Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket

A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.

Ki nem vehet részt

Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

Egyéb

  • Physicians not currently involved in the diagnosis or management of PV patients.
  • Medical trainees, residents, or fellows not yet board-certified or independently practicing.
  • Practicing outside of KSA or Ukraine or Türkiye.
  • Unwilling or unable to provide informed consent or complete the study procedures.

Kiket keres a vizsgálat

  • Board-certified or practicing hematology specialists actively managing PV patients.
  • Currently practicing in a hospital or clinic setting in the Kingdom of Saudi Arabia or Ukraine or Türkiye.
  • Minimum of 3 years of experience in the management of myeloproliferative neoplasms and/or hematological malignancies. Actively managing a minimum number of PV patients, defined as either:
  • Has managed at least 10 patients with PV during the past 3 to 5 years, or at least 3 to 5 patients with PV during the past 12 months.
  • Willing and able to provide informed consent and participate in a standardized survey and vignette assessment in a language in which the approved study materials are available, including English, Turkish, or Ukrainian, as applicable to the participating country.

A regiszterben nem jelölt feltételek

  • This study is based on physician responses to standardized clinical vignettes. Therefore, eligibility applies to participating physicians:

Nem: nők és férfiak · Egészséges önkénteseket nem fogad

A teljes feltétellista: ClinicalTrials.gov

Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.